Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




GE Healthcare to Support Emerging Market Health

By HospiMedica International staff writers
Posted on 05 Oct 2015
GE Healthcare (GE; Little Chalfont, United Kingdom) has announced the creation of a new business unit that will develop solutions to improve emerging market health outcomes.

The new Sustainable Healthcare Solutions (SHS) business will focus on the expansion of the company’s affordable healthcare portfolio, including the development of high value, low-cost technologies and business innovation models across multiple care settings in 70 markets, including India & South Asia, Africa, and Southeast Asia, with a focus on increasing access for 5.8 billion people around the world without basic health. More...
GE Healthcare will invest USD 300 million in SHS, as part of a multiphase effort to develop a more robust affordable healthcare portfolio for customers.

In a press release, GE Healthcare stated that with the vision to improve access to quality and affordable health around the world, SHS will work with governments, clinicians, private operators and non-government organizations (NGOs), reinforcing the company’s ongoing commitment to supporting the global healthcare ecosystem in attaining the new 2030 Sustainable Development Goals that are scheduled for ratification at the UN General Assembly, to be held during September 2015 in New York (NY, USA).

“SHS will leverage GE’s Fastworks methodology to accelerate, test and rapidly commercialize relevant, affordable technologies. By taking this ‘start-up’ model approach we can rapidly test new ideas, products and services to maximize effectiveness for customers before we scale up,” said Terri Bresenham, President and CEO of GE Healthcare’s SHS unit. “From basic primary care delivery through to more complex, structural healthcare challenges, SHS will aim to combine GE Healthcare’s capabilities and scale with the local know-how and expertise of our partners across Africa, Southeast Asia, India, and South Asia.”

“Much of the world’s population is without adequate healthcare, and innovations that can create better patient outcomes in a sustainable way are urgently needed,” said John Flannery, President and CEO of GE Healthcare. “Many emerging economies are looking for experienced partners to help build skills, capacity and effective healthcare solutions for their patients.”

The low-cost healthcare equipment sector alone is now estimated to be worth over USD 8 billion, and is growing significantly as developing countries continue to invest in effective, long-term healthcare solutions to improve the health of their populations.

Related Links:

GE Healthcare



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.